SCHEMBL24342641

SCHEMBL24342641

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5oc6c(ccc7ccc8c9ccccc9oc8c76)c5c4)c4ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 5/20 0.41
▸ PLA2G4A P47712 5/20 0.41
▸ ALOX5 P09917 1/20 0.38
▸ PLA2G10 O15496 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ CYP1A1 P04798 2/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ AHR P35869 2/20 0.36
▸ ABCG2 Q9UNQ0 2/20 0.36
▸ FYN P06241 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24342847 0.99 PLA2G2A (0.39) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL24342841 0.97 PLA2G2A (0.44) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL24342809 0.95 PLA2G2A (0.42) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL19109810 0.95 PLA2G2A (0.39) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL17299548 0.92 PLA2G2A (0.48) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL24341880 0.91 CYP1A1 (0.38) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL19109907 0.90 MAPT (0.41) ALOX5KDM4EHPGDMAPTMEN1
SCHEMBL10122392 0.90 PLA2G2A (0.46) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL24343053 0.90 ALOX5 (0.40) PLA2G2APLA2G4AALOX5PLA2G10KDM4E
SCHEMBL24342759 0.90 ALOX5 (0.38) PLA2G2APLA2G4AALOX5PLA2G10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PLA2G2A 4537/4885PLA2G4A 4462/4885ALOX5 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback